Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis
The Lancet,

Forouzanfar MH et al. – Breast and cervical cancer are important causes of mortality in women aged ≥15 years. We undertook annual age-specific assessments of breast and cervical cancer in 187 countries.


  • Systematically collected cancer registry data on mortality and incidence, vital registration, and verbal autopsy data for the period 1980—2010
  • Modelled the mortality-to-incidence (MI) ratio using a hierarchical model
  • Vital registration and verbal autopsy were supplemented with incidence multiplied by the MI ratio to yield a comprehensive database of mortality rates
  • Used Gaussian process regression to develop estimates of mortality with uncertainty by age, sex, country, and year
  • Used out-of-sample predictive validity to select the final model
  • Estimates of incidence with uncertainty were also generated with mortality and MI ratios

  • Global breast cancer incidence increased from 641 000 (95% uncertainty intervals 610 000—750 000) cases in 1980 to 1 643 000 (1 421 000—1 782 000) cases in 2010, an annual rate of increase of 3·1%
  • Global cervical cancer incidence increased from 378 000 (256 000—489 000) cases per year in 1980 to 454 000 (318 000—620 000) cases per year in 2010—a 0·6% annual rate of increase
  • Breast cancer killed 425 000 (359 000—453 000) women in 2010, of whom 68 000 (62 000—74 000) were aged 15—49 years in developing countries
  • Cervical cancer death rates have been decreasing but the disease still killed 200 000 (139 000—276 000) women in 2010, of whom 46 000 (33 000—64 000) were aged 15—49 years in developing countries
  • Recorded pronounced variation in trend in breast cancer mortality across regions and countries

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Maintenance therapy in ovarian cancer Current Opinion in Oncology, August 15, 2014    Review Article

2 Incorporation of pazopanib in maintenance therapy of ovarian cancer Journal of Clinical Oncology, September 26, 2014    Clinical Article

3 High-grade undifferentiated sarcomas of the uterus: Diagnosis, outcomes, and new treatment approaches Current Oncology Reports, September 4, 2014    Clinical Article

4 Pathologic findings at risk-reducing salpingo-oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199 Journal of Clinical Oncology, September 22, 2014    Clinical Article

5 Menstrual pain and epithelial ovarian cancer risk Cancer Causes and Control, September 16, 2014    Clinical Article

6 Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer European Journal of Cancer, August 6, 2014    Clinical Article

7 Survival differences of serous tubal, ovarian, peritoneal and uterine carcinomas American Journal of Obstetrics and Gynecology, September 2, 2014    Clinical Article

8 Serum 25-hydroxyvitamin D, vitamin D binding protein, and risk of colorectal cancer in the prostate, Lung, colorectal, and Ovarian cancer screening trial International Journal of Cancer, August 25, 2014    Clinical Article

9 National trends and disparities in cervical cancer screening among commercially insured women, 2001-2010 Cancer Epidemiology, Biomarkers & Prevention, September 8, 2014

10 Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary International Journal of Gynecological Cancer, September 4, 2014    Evidence Based Medicine

11 Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer Tumor Biology, September 25, 2014    Clinical Article

12 Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study The Lancet Oncology, September 17, 2014    Clinical Article

13 Survival advantage associated with decrease in stage at detection from stage IIIC to stage IIIA epithelial ovarian cancer Full Text Journal of Oncology, September 22, 2014    Free full text    Clinical Article

14 MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2 Tumor Biology, September 22, 2014    Clinical Article

15 Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability Molecular Carcinogenesis, September 11, 2014    Clinical Article

16 Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada Full Text Hereditary Cancer in Clinical Practice, September 19, 2014    Free full text    Clinical Article

17 Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy Current Opinion in Oncology, August 11, 2014    Review Article

18 Intrauterine devices and endometrial cancer risk: a pooled analysis of the epidemiology of endometrial cancer consortium Annals of Epidemiology , August 29, 2014    Clinical Article

19 Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial The Lancet Oncology, July 1, 2014    Clinical Article

20 Adult granulosa cell tumours of the ovary Current Opinion in Oncology, August 15, 2014    Review Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More